GT BIOPHARMA INC (GTBP)       1.85  +0.09 (+5.11%)

1.85  +0.09 (+5.11%)

US36254L2097 - Common Stock - After market: 1.85 0 (0%)

Buy % Consensus

Analysts have set a mean price target of 4.08. This target is 120.54% above the current price.
GTBP was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GTBP.
In the previous month the buy percentage consensus was at a similar level.
GTBP was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target

Price Low Median Mean High 1.853. - 63.78% 120.54% 120.54% 183.78%

Up and Down Grades

Date Firm Action Rating
2022-09-13 HC Wainwright & Co. Maintains Buy
2021-05-24 HC Wainwright & Co. Initiate Buy
2021-04-13 B. Riley FBR Initiate Buy
2021-03-17 Roth Capital Initiate Buy

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA